The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
ferrer internacional | 119 |
nicox | 7 |
ferrer int | 5 |
ferrer international | 2 |
ferrer internasional | 1 |
ferrer internac | 1 |
ferrer internacional | 10 |
abac therapeutics, s.l. | 4 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
oral formulation for the treatment of cardiovascular diseases | 50 | 2013 |
pharmaceutical topical compositions | 47 | 2008 |
capsule for the prevention of cardiovascular diseases | 35 | 2008 |
1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-1,4-dihydro-3-quin… 🛈 | 26 | 2010 |
process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound | 25 | 2006 |
polymorph b of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-p… 🛈 | 24 | 2006 |
imidazo [1, 2-b]pyridazines, their processes of preparation and their use as gaba recept… 🛈 | 24 | 2006 |
halogenated pyrazolo [1,5-a]pyrimidines, processes, uses as gaba-a receptors ligand, com… 🛈 | 23 | 2005 |
amorphous form of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo [1,5-a]pyrimidin-7-yl… 🛈 | 22 | 2006 |
3-cyanopyrrolidinyl-phenyl-oxazolidinones as antibacterial agents | 22 | 2008 |